Hirsutism Clinical Trial
Official title:
Body Composition, Insulin Concentration, Androgens and Bone Status in Women Referred With Hirsutism
The purpose of this study is to investigate how the bones of hirsute women are different
from bones of healthy women. The change in hormone content in the blood will also be
investigated. The study can be used to evaluate whether it will be relevant to bone scan all
newly referred hirsute women.
Hirsute women are often over-weight and often have an increased amount of the male sex
hormone in their blood. Their blood tests often show changes reminding of the ones seen in
diabetic patients.
All hirsute women referred to the department will undergo an investigation revealing the
reason for the increased hair growth. The investigation includes clinical investigation
(height, weight and degree of hair growth), blood tests (for hormone status and bone status
analysis) and bone scanning of the abdomen (body composition).
The trial includes a group of 50 strongly hairy women and a control group of 50 healthy
women with normal hair growth. They are matched by body weight, since weight has great
importance for the bone mineral content and thereby for osteoporosis in the long run.
n/a
Observational Model: Case Control, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02103608 -
Clinical Evaluation of Silk'n Glide for Face
|
N/A | |
| Not yet recruiting |
NCT00495443 -
Enhanced Safety Aesthetic Laser System
|
N/A | |
| Not yet recruiting |
NCT06003062 -
Suppression of Upper Lip Hair Growth Using Novel Hemp Extract
|
||
| Active, not recruiting |
NCT00145288 -
Prospective Study of Patients With Hirsutism
|
Phase 2/Phase 3 | |
| Completed |
NCT00152048 -
Evaluation of Eflornithine on Facial and Forearm Skin
|
Phase 4 | |
| Enrolling by invitation |
NCT01461694 -
Facial Hair Reduction Using Intense Pulsed Light (IPL) & Alexandrite Laser
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT00441948 -
Enhanced Safety Laser Hair Removal System
|
N/A | |
| Completed |
NCT03673995 -
Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS
|
N/A | |
| Recruiting |
NCT04979377 -
Prevalence of Hyperandrogenism in Type 1 Diabetes
|
||
| Completed |
NCT02494297 -
DUS on the Prescribing Indications for CPA/EE in 5 European Countries
|
||
| Completed |
NCT00960310 -
Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions
|
Phase 1 | |
| Completed |
NCT02793557 -
Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth
|
Phase 1/Phase 2 | |
| Completed |
NCT01817894 -
Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism
|
Phase 4 | |
| Completed |
NCT01555190 -
Combination Therapy With Myo-inositol and Folic Acid Versus Myo-inositol Alone
|
N/A | |
| Recruiting |
NCT01338519 -
Database Study on Patients With PCOS
|
N/A | |
| Recruiting |
NCT04292587 -
Prevalence of Hirsutism in Turkey: Data of The Dermatoendocrinology Study Group
|
||
| Completed |
NCT00959335 -
Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions
|
Phase 1 | |
| Not yet recruiting |
NCT00371930 -
Photodynamic Therapy for Permanent Hair Removal
|
Phase 1/Phase 2 |